Long term study of the effect of rifampicin and isoniazid on vitamin D metabolismWILLIAMS, S. E; WARDMAN, A. G; TAYLOR, G. A et al.Tubercle. 1985, Vol 66, Num 1, pp 49-54, issn 0041-3879Article

Evolution of short-course antimicrobial treatment of tuberculosis in children, 1951-1984KENDIG, E. L. JR.Pediatrics (Evanston). 1985, Vol 75, Num 4, pp 684-686, issn 0031-4005Article

Antituberculosis agentsGOLDBERGER, M. J.The Medical clinics of North America. 1988, Vol 72, Num 3, pp 661-668, issn 0025-7125Article

Tuberkulostatische Wirkung der Piperidinoethylester der Alkoxyphenylcarbamidsäuren in vitro = Activité tuberculostatique du pipéridinoéthylester du alkoxyphénylcarbamide in vitro = Tuberculostatic activity of the piperidinoethyl ester of the alkoxyphenylcarbamide acid in vitroCIZMARIK, J; SVEJNOCHOVA, M; SCHWARTZ, E et al.Pharmazie. 1986, Vol 41, Num 10, pp 744-745, issn 0031-7144Article

Selman Waksman (1888-1973), discoverer of streptomycin: a centenary reviewSAKULA, A.British journal of diseases of the chest. 1988, Vol 82, Num 1, pp 23-31, issn 0007-0971Article

Variability in the intradermal and in vitro lymphocyte responses to PPD in patients receiving isoniazid chemoprophylaxisTAGER, I. B; KALAIDJIAN, R; BALDINI, L et al.The American review of respiratory disease. 1985, Vol 131, Num 2, pp 214-220, issn 0003-0805Article

Correspondence with a pioneer, Jürgen Lehmann (1988-1989), producer of the first effective antituberculosis specificDUBOVSKY, H.SAMJ. South African medical journal. 1991, Vol 79, Num 1, pp 48-50, issn 0256-9574, 3 p.Article

Microdosage de l'isoniazide et de l'acetylisoniazide plasmatiques par chromatographie liquide à haute performance = Determination of isoniazid and acetylisoniazid in plasma or serum by high-performance liquid chromatographyLACROIX, C; LAINE, G; GOULLE, J. P et al.Journal of chromatography. 1984, Vol 307, Num 1, pp 137-144, issn 0021-9673Article

Deoxysugars as Antituberculars and Alpha-Mannosidase InhibitorsKASHYAP, Vivek; SHARMA, Smriti; SINGH, Vinayak et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 6, pp 3530-3532, issn 0066-4804, 3 p.Article

Les antituberculeux = Tuberculosis chemotherapyRADERMECKER, M.RMLG. Revue médicale de Liège. 1996, Vol 51, Num 1, pp 44-46, issn 0370-629XArticle

Dosage of thiacetazonePEARSON, C. A.Lancet (British edition). 1992, Vol 339, Num 8792, pp 553-554, issn 0140-6736Article

5-Hydroxypyrazinamide, a human metabolite of pyrazinamideYAMAMOTO, T; MORIWAKI, Y; TAKAHASHI, S et al.Biochemical pharmacology. 1987, Vol 36, Num 14, pp 2415-2416, issn 0006-2952Article

A review of blood dyscrasias induced by the antituberculosis drugsHOLDINESS, M. R.Tubercle. 1987, Vol 68, Num 4, pp 301-309, issn 0041-3879Article

Determination of minimal inhibitory concentrations of antituberculosis drugs by radiometric and conventional methodsCHUN-NIN LEE; HEIFETS, L. B.The American review of respiratory disease. 1987, Vol 136, Num 2, pp 349-352, issn 0003-0805Article

Rifampicin kinetics in undernutritionKALPAGAM POLASA; MURTHY, K. J. R; KAMALA KRISHNASWAMY et al.British journal of clinical pharmacology. 1984, Vol 17, Num 4, pp 481-484, issn 0306-5251Article

In Vitro Interactions between New Antitubercular Drug Candidates SQ109 and TMC207REDDY, Venkata M; EINCK, Leo; ANDRIES, K et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 7, pp 2840-2846, issn 0066-4804, 7 p.Article

New Drugs against Tuberculosis : Problems, Progress, and Evaluation of Agents in Clinical DevelopmentVAN DEN BOOGAARD, Jossy; KIBIKI, Gibson S; KISANGA, Elton R et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 3, pp 849-862, issn 0066-4804, 14 p.Article

Severe «flu»-like symptoms due to isoniazid. A report of three casesMOTION, S; HUMPHRIES, M. J; GABRIEL, M et al.Tubercle. 1989, Vol 70, Num 1, pp 57-60, issn 0041-3879Article

The action of antituberculosis drugs in short-course chemotherapyMITCHISON, D. A.Tubercle. 1985, Vol 66, Num 3, pp 219-225, issn 0041-3879Article

Spectrophotometric determination of isoniazid using ethyl 8-quinolinoxy acetateAHMED, A.-H. N; EL GIZAWY, S. M. E; SUBBAGH, H. I. E et al.Analytical letters. 1992, Vol 25, Num 1, pp 73-80, issn 0003-2719Article

Faut-il adapter la posologie de l'isoniazide? = Should the isoniazid dose regimen be ajusted?KHALIFE, K; TRECHOT, P; JUILLIÈRE, Y et al.Médecine et hygiène. 1985, Vol 43, Num 1596, pp 383-386, issn 0025-6749Article

Symposium satellite sur le contrôle de qualité des médicaments antituberculeux, Dubrovnik, 6 octobre 1988 = Symposium about the quality control of antituberculous agents, Dubrovnik, 1988, October the 6thBulletin de l'Union internationale contre la tuberculose et les maladies respiratoires. 1989, Vol 64, Num 1, pp 38-43, issn 1011-7903Conference Paper

Aspects of the antituberculous activity of 27753-RP, a new semisynthetic derivative of griselimycineTOYOHARA, M.Annales de l'Institut Pasteur. Microbiologie. 1987, Vol 138, Num 6, pp 737-744, issn 0769-2609Article

Use of Clofazimine in DermatologyGURFINKEL, Paula; CARNEVALE PINA, Juliana; RAMOS-E-SILVA, Marcia et al.Journal of drugs in dermatology. 2009, Vol 8, Num 9, pp 846-851, issn 1545-9616, 6 p.Article

Administration of anti-tuberculosis drugs through patient empowermentBANERJEE, A; SALANIPONI, F; HARRIES, A et al.Tropical doctor. 1997, Vol 27, Num 4, issn 0049-4755, p. 240Article